Nav: Home

Synthetic carbohydrates against autoimmune diseases

April 17, 2017

Researchers are developing an innovative approach for the treatment of a rare autoimmune disease of the peripheral nervous system, using a type of molecular sponge consisting of carbohydrates to remove pathogenic antibodies from the bloodstream. Developed to treat anti-MAG neuropathy, the approach also has potential applications for the treatment of other autoimmune diseases. Scientists from the University of Basel and University Hospital Basel have reported their findings in the scientific journal PNAS.

Patients with anti-MAG neuropathy predominantly suffer from sensory loss in their arms and legs, neuropathic pain, and a loss of coordination that can substantially impair mobility. Through progressive damage to the peripheral nerves, the patients become increasingly disabled in their day-to-day lives until they require full-time care.

The disease is diagnosed based on the presence of blood serum autoantibodies that bind to the myelin-associated glycoprotein (MAG) in the peripheral nervous system. These anti-MAG antibodies have long been recognized as the cause of the disease. Furthermore, a reduction of the antibody concentration in the blood leads to an improvement in the symptoms.

To date, no approved treatment is available that specifically targets these autoantibodies. Current therapies are directed to suppress the immune response; they are inefficient and in some cases cause serious side effects.

Artificial molecule as a sponge

Basel-based researchers are thus working on a new treatment approach with customized synthetic glycopolymers that act like a sponge on the harmful autoantibodies. The glycopolymer mimicks the section of the MAG protein the anti-MAG antibodies are binding to.

The scientists could show in vitro that the glycopolymer neutralizes the disease-causing antibodies in patient sera and more importantly, that the anti-MAG antibodies could be effectively removed in immunized mice.

Potential for other autoimmune diseases

This new treatment method offers significant potential not only for an antigen-specific treatment of anti-MAG neuropathy but also for other antibody-mediated autoimmune diseases.

Currently, only fragmentary knowledge of the antigens in many autoimmune diseases is available. Antigen-specific therapies are therefore very difficult to develop. "The use of our glycopolymers opens up new possibilities for the treatment of diseases where anti-glycan antibodies play a role," says study director Professor Beat Ernst from the Department of Pharmaceutical Sciences at the University of Basel. Examples of such diseases include multifocal motor neuropathy or Guillain-Barré syndrome.

Collaboration with spin-off

These findings are the result of a joint project between the University of Basel's Department of Pharmaceutical Sciences and Polyneuron Pharmaceuticals AG, a University of Basel spin-off founded by Dr. Ruben Herrendorff, Professor Andreas Steck and Professor Beat Ernst in 2014. The project was funded by the Commission for Technology and Innovation (CTI), the Gebert Rüf Foundation, and the Neuromuscular Research Association Basel.

Polyneuron Pharmaceuticals AG is currently preparing for a clinical trial with the glycopolymer drug for the treatment of anti-MAG neuropathy.
-end-


University of Basel

Related Autoimmune Diseases Articles:

Cellular stress increases the probability of developing autoimmune diseases
Researchers found that cellular stress enhances the activation of certain type of immune cells with implications in many chronic inflammatory conditions.
Smoking decreases MAIT cells, implicated in the pathology of autoimmune diseases
New research published in the May 2017 issue of the Journal of Leukocyte Biology provides another reason why smoking tobacco is harmful.
Researchers describe ultrasensitive detection of protein linked to multiple autoimmune diseases
Researchers in France have developed a new method that will allow doctors to detect minute amounts of a protein called interferon- in patient samples.
Synthetic carbohydrates against autoimmune diseases
Researchers are developing an innovative approach for the treatment of a rare autoimmune disease of the peripheral nervous system, using a type of molecular sponge consisting of carbohydrates to remove pathogenic antibodies from the bloodstream.
Cargo-carrying red blood cells alleviate autoimmune diseases in mice
Using red blood cells modified to carry disease-specific antigens, a team of scientists from Whitehead Institute and Boston Children's Hospital have prevented and alleviated two autoimmune diseases -- multiple sclerosis (MS) and type 1 diabetes --i n early stage mouse models.
Study of complex genetic region finds hidden role of NCF1 in multiple autoimmune diseases
Medical University of South Carolina investigators report pre-clinical research showing that a genetic variant encoded in neutrophil cystolic factor 1 (NCF1) is associated with increased risk for autoimmune diseases, including systemic lupus erythematosus (SLE), rheumatoid arthritis, and Sjögren's syndrome, in the January 2017 issue of Nature Genetics.
'Master regulator' in genes may make women more susceptible to autoimmune diseases
New research identifies an inflammatory pathway in women that could help explain why they develop autoimmune diseases at a much higher rate than men.
Thwarting autoimmune diseases
The immunoproteasome dismantles proteins and the resulting fragments are displayed on the surface of cells.
HPV vaccine found safe in girls and women with autoimmune diseases
In a recent study of girls and women diagnosed with at least one autoimmune disease, vaccination against human papillomavirus (HPV) did not increase the risk of developing another autoimmune disease.
Cancer drugs could target autoimmune diseases
Drugs currently being trialled in cancer patients have been used to successfully target an autoimmune condition in mice at UCL and King's College London.

Related Autoimmune Diseases Reading:

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Setbacks
Failure can feel lonely and final. But can we learn from failure, even reframe it, to feel more like a temporary setback? This hour, TED speakers on changing a crushing defeat into a stepping stone. Guests include entrepreneur Leticia Gasca, psychology professor Alison Ledgerwood, astronomer Phil Plait, former professional athlete Charly Haversat, and UPS training manager Jon Bowers.
Now Playing: Science for the People

#524 The Human Network
What does a network of humans look like and how does it work? How does information spread? How do decisions and opinions spread? What gets distorted as it moves through the network and why? This week we dig into the ins and outs of human networks with Matthew Jackson, Professor of Economics at Stanford University and author of the book "The Human Network: How Your Social Position Determines Your Power, Beliefs, and Behaviours".